Cytochroma Inc, Kingston ON, has expanded its R&D collaboration with Allergan, Irvine CA to develop inhibitors of retinoic acid metabolism. The two firms have already successfully completed initial research on two cytochrome enzymes responsible for the breakdown of retinoic acid in humans. The exploration of new indicators is covered in the new agreement, which spans three years and includes additional milestone payments and increased royalty streams on product sales....